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It seems obvious that the number of
pathogens should be important in the
pathogenesis of an infectious disease
[1,2]. The relationship between the path-
ogen load and severity is one of the most
fundamental questions, and yet, strangely,
one of the most difficult to answer [3].
One reason for this is that it is often rather
difficult to determine the total pathogen
load in an infected host, particularly in an
infected human. Pathogens can be distrib-
uted, non-uniformly, throughout multiple
different cell, tissue, or organ compart-
ments of the body, many of which are
difficult to sample. For this reason, we are
often constrained by measuring pathogen
load in the samples that are readily
accessible such as blood, urine, and
sputum, and we must assume that these
are representative of total pathogen load.
The success of this approach is borne out
by the usefulness of these measurements to
guide clinical management of patients with
some infections [4,5], but it is also well
recognised that these methods are imper-
fect [6,7]. Variations in both pathogen and
host can alter distribution of the pathogen
and the likelihood that a given pathogen
burden will cause disease [1,2,8–11].
Imperfect estimation of pathogen load
becomes a particularly important problem
when trying to understand host responses
to infection, and their role in pathogenesis.
In order to interpret whether a host
response is insufficient, appropriate, or
excessive, it needs to be assessed in relation
to the pathogen load that triggered it.
In this issue of PLOS Pathogens,
Nicholas Anstey and colleagues present
an analysis of host responses in relation to
pathogen load in both Plasmodium vivax
and P. falciparum malaria [12]. These
authors have previously been instrumental
in demonstrating that along with P.
falciparum, P. vivax is an important cause
of severe malaria, morbidity, and mortal-
ity [13,14]. Their current findings help us
to understand why and illustrate the
importance of trying to determine patho-
gen load and distribution. Measurement of
pathogen load in malaria might seem
simple because illness only occurs during
the phase of asexual parasite replication
within red blood cells. Thus, malaria is
often diagnosed by microscopic examina-
tion of a blood sample, and the simplest
metric of pathogen load is assessment of
parasitemia—the percentage of infected
red blood cells (iRBCs). However, anemia
is a common consequence of malaria, and
so the pathogen burden in blood is more
accurately quantified by calculation of the
absolute parasite density in blood, taking
account of the number of red blood cells
per mL. Even this refinement can be very
misleading with certain species of Plasmo-
dium (notably P. falciparum and the
common ‘‘mouse model’’ parasite P.
berghei ANKA) because iRBCs can adhere
to the endothelium, which lines small
blood vessels (sequestration), resulting in
their under-representation in circulating
blood [15]. Methods have been developed
to estimate total parasite load (parasite
biomass) in P. falciparum malaria by
measuring the plasma concentration of
parasite molecules, which are released into
the host circulation, and demonstrate that
this is a much better predictor of severity
than measurement of the circulating
parasites alone [15–18]. In addition, the
proportion of parasites that are seques-
tered is particularly high in some manifes-
tations of severe malaria [11,15,16,19].
Anstey and colleagues propose a method
to approximate the total parasite biomass
in P. vivax malaria using the plasma
concentration of parasite lactate dehydro-
genase (LDH) [12]. Similar to the estab-
lished finding in P. falciparum malaria,
total P. vivax parasite biomass appears
higher in severe than uncomplicated
malaria, and also appears to be underes-
timated by counting parasites in the
peripheral blood. Since P. vivax iRBCs
exhibit much less endothelial adhesion
than P. falciparum iRBCs [20], the
authors propose that P. vivax may accu-
mulate outside of the endothelium-lined
compartments of the blood, possibly in the
slow open circulation of the spleen. This
explanation is appealing, but there are
some important caveats. First, P. vivax
biomass is assumed to be approximately
proportional to the plasma concentration
of parasite LDH, but this will only be true
if this molecule is released evenly through-
out the parasite lifecycle or if there is an
even distribution of life cycle stages at any
point in time (i.e., the infection is totally
asynchronous). Whilst all subjects had
over-representation of younger parasite
stages in the blood, there was no difference
in this distribution between subjects with
severe and uncomplicated P. vivax malar-
ia, meaning that comparison of parasite
LDH between groups should be valid.
Second, the rate of production and
clearance of parasite LDH could vary
between subjects with severe and uncom-
plicated malaria, resulting in differences in
plasma concentration that are not solely
due to parasite biomass. Thus, parasite
LDH probably only gives a semi-quanti-
tative estimate of P. vivax biomass.
Despite these limitations, Anstey and
colleagues are to be congratulated for
applying this methodology to produce a
unique assessment of the relationship
between parasite biomass and the major
determinants of severe malaria pathogen-
esis: inflammation, sequestration, and
vascular endothelial dysfunction [15,19].
Their data are all the more remarkable
because they compare large numbers of
healthy controls and subjects with both P.
falciparum and P. vivax malaria [12].
Whilst there appear to be many similari-
ties between severe disease caused by both
parasite species, it is only when parasite
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biomass and distribution are considered
that distinct pathogenic mechanisms begin
to be revealed. In P. vivax malaria, the
parasite LDH concentration correlates
with the systemic inflammatory response,
but not with markers of endothelial
activation. In contrast, circulating parasit-
emia correlates much better with endo-
thelial activation. This is intriguing be-
cause it suggests that somehow the
circulating parasites are activating the
vascular endothelium independent of sol-
uble circulating factors (which would also
arise from the non-circulating parasites).
Does this mean that some sort of non-
adhesive interaction between circulating
iRBCs and endothelial cells triggers endo-
thelial activation? Further research will be
necessary to answer this question. But it
may also provide insights into a long-
standing debate about whether endothelial
sequestration of P. falciparum is the cause,
or a consequence, of endothelial activation
[15,21]. In humans with P. falciparum,
these two phenomena are often so closely
correlated that they are impossible to
separate, but we now know that for P.
vivax at least, endothelial activation can
occur independent of endothelial parasite
sequestration.
Whilst the study by Anstey and col-
leagues clearly illustrates the importance of
assessing pathogen load [12], even this
approach is oversimplified. Quite apart
from the complexities of how and where to
measure pathogen load, there is also the
question of when to measure it? In
naturally acquired, serious infections in
humans, we rarely have a choice in this
matter—we can only measure it at the
time they present for treatment. But the
pathogen load at this point in time is the
consequence of a dynamic interplay be-
tween the rate of pathogen replication,
how long the pathogen has had to
replicate (the number of replication cycles)
before the person seeks medical attention,
and how effectively the host response
constrains pathogen replication. Beyond
measuring pathogen load, in the future we
need to consider new methods that will
allow us to interpret pathogen load in this
dynamic context.
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